Patrick M Fisher1, Martin K Madsen1, Brenda Mc Mahon1, Klaus K Holst2, Sofie B Andersen1, Helle R Laursen3, Lis F Hasholt4, Hartwig R Siebner3, Gitte M Knudsen5. 1. Center for Integrated Molecular Brain Imaging, Copenhagen University Hospital Rigshospitalet, Copenhagen O; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen O. 2. Center for Integrated Molecular Brain Imaging, Copenhagen University Hospital Rigshospitalet, Copenhagen O; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen O; Department of Biostatistics, University of Copenhagen, Copenhagen K. 3. Center for Integrated Molecular Brain Imaging, Copenhagen University Hospital Rigshospitalet, Copenhagen O; Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, Hvidovre. 4. Department of Cellular and Molecular Medicine, Copenhagen University, Copenhagen, Denmark. 5. Center for Integrated Molecular Brain Imaging, Copenhagen University Hospital Rigshospitalet, Copenhagen O; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen O. Electronic address: gmk@nru.dk.
Abstract
BACKGROUND: Bright-light intervention is reported to successfully treat depression, in particular seasonal affective disorder, but the neural pathways and molecular mechanisms mediating its effects are unclear. An amygdala-prefrontal cortex corticolimbic circuit regulates responses to salient environmental stimuli (e.g., threat) and may underlie these effects. Serotonin signaling modulates this circuit and is implicated in the pathophysiology of seasonal and other affective disorders. METHODS: We evaluated the effects of a bright-light intervention protocol on threat-related corticolimbic reactivity and functional coupling, assessed with an emotional faces functional magnetic resonance imaging paradigm at preintervention and postintervention. In a double-blind study conducted in the winter, 30 healthy male subjects received bright-light intervention (dose range between participants: .1-11.0 kilolux) for 30 minutes daily over a period of 3 weeks. Additionally, we considered serotonin transporter-linked polymorphic region (5-HTTLPR) genotype status as a model for differences in serotonin signaling and moderator of intervention effects. RESULTS: Bright-light dose significantly negatively affected threat-related amygdala and prefrontal reactivity in a dose-dependent manner. Conversely, amygdala-prefrontal and intraprefrontal functional coupling increased significantly in a dose-dependent manner. Genotype status significantly moderated bright-light intervention effects on intraprefrontal functional coupling. CONCLUSIONS: This is the first study to evaluate the effects of clinically relevant bright-light intervention on threat-related brain function. We show that amygdala-prefrontal reactivity and communication are significantly affected by bright-light intervention, an effect partly moderated by genotype. These novel findings support that this threat-related corticolimbic circuit is sensitive to light intervention and may mediate the therapeutic effects of bright-light intervention.
BACKGROUND: Bright-light intervention is reported to successfully treat depression, in particular seasonal affective disorder, but the neural pathways and molecular mechanisms mediating its effects are unclear. An amygdala-prefrontal cortex corticolimbic circuit regulates responses to salient environmental stimuli (e.g., threat) and may underlie these effects. Serotonin signaling modulates this circuit and is implicated in the pathophysiology of seasonal and other affective disorders. METHODS: We evaluated the effects of a bright-light intervention protocol on threat-related corticolimbic reactivity and functional coupling, assessed with an emotional faces functional magnetic resonance imaging paradigm at preintervention and postintervention. In a double-blind study conducted in the winter, 30 healthy male subjects received bright-light intervention (dose range between participants: .1-11.0 kilolux) for 30 minutes daily over a period of 3 weeks. Additionally, we considered serotonin transporter-linked polymorphic region (5-HTTLPR) genotype status as a model for differences in serotonin signaling and moderator of intervention effects. RESULTS: Bright-light dose significantly negatively affected threat-related amygdala and prefrontal reactivity in a dose-dependent manner. Conversely, amygdala-prefrontal and intraprefrontal functional coupling increased significantly in a dose-dependent manner. Genotype status significantly moderated bright-light intervention effects on intraprefrontal functional coupling. CONCLUSIONS: This is the first study to evaluate the effects of clinically relevant bright-light intervention on threat-related brain function. We show that amygdala-prefrontal reactivity and communication are significantly affected by bright-light intervention, an effect partly moderated by genotype. These novel findings support that this threat-related corticolimbic circuit is sensitive to light intervention and may mediate the therapeutic effects of bright-light intervention.
Authors: Patrick M Fisher; Cheryl L Grady; Martin K Madsen; Stephen C Strother; Gitte M Knudsen Journal: Hum Brain Mapp Date: 2015-04-30 Impact factor: 5.038
Authors: David P Cenkner; Helen J Burgess; Brooke Huizenga; Elizabeth R Duval; Hyungjin Myra Kim; K Luan Phan; Israel Liberzon; Heide Klumpp; James Abelson; Adam Horwitz; Ann Mooney; Greta B Raglan; Alyson K Zalta Journal: PLoS One Date: 2022-06-08 Impact factor: 3.752
Authors: Martin Nørgaard; Melanie Ganz; Claus Svarer; Patrick M Fisher; Nathan W Churchill; Vincent Beliveau; Cheryl Grady; Stephen C Strother; Gitte M Knudsen Journal: Front Neurosci Date: 2017-11-03 Impact factor: 4.677
Authors: Anna Alkozei; Natalie S Dailey; Sahil Bajaj; John R Vanuk; Adam C Raikes; William D S Killgore Journal: Front Neurol Date: 2021-03-26 Impact factor: 4.003